Category: New products
-
Gut Microbe Drug Shown to Prevent Return Infections
Early results from a clinical trial show an oral drug taken one time prevents more recurring infections from harmful gut bacteria than conventional treatments.
-
Program Reduces Long-Term Care Covid-19 Outbreaks
A collaborative program between an academic medical center and long-term care homes for older residents helps reduce Covid-19 infection outbreaks and deaths.
-
Non-Invasive Fetal Oxygen Monitor Designed
A university engineering lab created a device that safely monitors a fetus’s blood oxygen levels from outside the mother’s abdomen, which could reduce the rate of cesarean sections.
-
Covid-19 Dual Therapy Drug Trial Okayed
A company developing an oral drug that treats both Covid-19 infections and overactive immune system reactions received regulatory approval for a later-stage clinical trial.
-
FDA Clears Video Game ADHD Therapy
A video game designed to help children improve their inattention and other symptoms of ADHD received authorization from the U.S. Food and Drug Administration.
-
Covid-19 Antibody Cocktail to Begin Clinical Trial
A combination of two synthetic antibodies, with an enhanced infection-blocking design for preventing and treating Covid-19 infections, is set to begin a clinical trial.
-
Crispr Heart Disease Start-Up Raises New $63M
A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round.
-
Foundations Back ALS Biomarker Study
Two organizations supporting research on amyotrophic lateral sclerosis or ALS are funding a study of changes to chemical indicators in the body responding to ALS drugs.
-
Trial Indicates App Helps Treat Behavior Disorder
Results of a clinical trial suggest a smartphone app designed for use in a therapy program helps some people control their obsessive-compulsive disorder.
-
Covid-19 Vaccine for Lower-Income Regions Underway
Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries.